Phosphorylation of the src epithelial substrate trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers

Clinical Cancer Research

Volumn 15, Issue 7, 2009, Pages 2311-2322

  Wong, Ching Hang ^a   Baehner, Frederick L ^a   Spassov, Danislav S ^a   Ahuja, Deepika ^a   Wang, Donghui ^b   Hann, Byron ^b   Blair, Jimmy ^c   Shokat, Kevan ^c   Welm, Alana L ^c   Moasser, Mark M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN TRASK; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; ENZYME SUBSTRATE; EPITHELIUM CELL; EPITHELIUM TUMOR; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTIGENS, CD; BREAST NEOPLASMS; CARCINOMA; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; NEOPLASM PROTEINS; PHOSPHORYLATION; SRC-FAMILY KINASES;

EID: 65249184413     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2533     Document Type: Article

References (39)

1. Martin GS. The road to Src. Oncogene 2004;23: 7910-7.
2. Cartwright CA, Eckhart W, Simon S, Kaplan PL. Cell transformation bypp60c-src mutated in the carboxy- terminal regulatory domain. Cell 1987;49:83-91.
3. Jove R, Hanafusa H. Cell transformation by the viral src oncogene. Annu Rev Cell Biol 1987;3:31 -56.
4. IrbyRB, Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene 2000;19: 5636-42.
5. Muthuswamy SK, MullerWJ. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Oncogene 1995;11: 1801 -10.
6. GuyCT, Cardiff RD, MullerWJ. Induction of mammary tumors by expression of polyomavirus middle Toncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992;12:954-61.
7. GuyCT, Muthuswamy SK, Cardiff RD, Soriano P, MullerWJ. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 1994;8:23-32.
8. TanM,LiP,KlosKS, et al. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis. Cancer Res 2005;65:1858-67.
9. Pories SE, Hess DT, Swenson K, et al. Overexpression of pp60c-src elicits invasive behavior in rat colon epithelial cells. Gastroenterology1998;114:1287- 95.
10. Vultur A, Buettner R, Kowolik C, et al. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol CancerTher 2008;7:1185-94.
11. Ito H, Gardner-Thorpe J, Zinner MJ, Ashley SW, Whang EE. Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness. Surgery 2003;134:221-6.
12. Yezhelyev MV, Koehl G, Guba M, et al. Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Clin Cancer Res 2004;10:8028-36.
13. Boyer B, Bourgeois Y, Poupon MF. Src kinase contributes to the metastatic spread of carcinoma cells. Oncogene 2002;21:2347-56.
14. Frame MC. Newest findings on the oldest oncogene; How activated src does it. J Cell Sci 2004;117: 989-98.
15. Frame MC, FinchamVJ, Carragher NO, Wyke JA. v-Src's hold over actin and cell adhesions. [Review] [119 refs]. Nat Rev Mol Cell Biol 2002;3:233-45.
16. IshizawarR, Parsons SJ. c-Src and cooperating partners in human cancer. Cancer Cell 2004;6:209 -14.
17. Bhatt AS, Erdjument-Bromage H,Tempst P, Craik CS, Moasser MM. Adhesion signaling bya novel mitotic substrate of src kinases. Oncogene 2005;24: 5333-43.
18. Bhatt AS,Welm A, FaradyCJ,Vasquez M,Wilson K, Craik CS. Coordinate expression and functional profiling identifyan extracellular proteolytic signaling pathway. Proc Natl Acad Sci U S A 2007;104: 5771 -6.
19. Bhatt AS, Takeuchi T,Ylstra B, et al. Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells. Biol Chem 2003;384: 257-66.
20. Scherl-Mostageer M, SommergruberW, Abseher R, Hauptmann R, Ambros P, Schweifer N. Identification of a novel gene, CDCP1, overexpressed in human co- lorectal cancer. Oncogene 2001;20:4402-8.
21. Perry SE, Robinson P, Melcher A, et al. Expression of the CUB domain containing protein1 (CDCP1) genein colorectal tumour cells. FEBS Lett 2007;581:1137-42.
22. Hooper JD, Zijlstra A, Aimes RT, et al. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Oncogene 2003;22:1783-94.
23. Welm AL, Sneddon JB, Taylor C, et al. The macro- phage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc Natl Acad Sci U S A 2007;104:7570-5.
24. WindhamTC, Parikh NU, Siwak DR, et al. Src activation regulates anoikis in human colon tumor cell lines. Oncogene 2002;21:7797-807.
25. WeiL,Yang Y,Zhang X,Yu Q. Altered regulation of Srcupon cell detachment protects humanlung adeno- carcinoma cells from anoikis. Oncogene 2004;23: 9052-61.
26. Loza-Coll MA, Perera S, Shi W, Filmus J. A transient increase in the activity of Src-family kinases induced bycell detachment delays anoikis of intestinal epithelial cells. Oncogene 2005;24:1727-37.
27. UekitaT,JiaL, Narisawa-SaitoM,YokotaJ,KiyonoT, Sakai R. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocar- cinoma. Mol Cell Biol 2007;27:7649-60.
28. Cartwright CA, Meisler AI, Eckhart W. Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci U S A 1990;87:558-62.
29. Pena SV, Melhem MF, Meisler AI, Cartwright CA. Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon [see comments]. Gastroenterology 1995:108:117-24.
30. Iravani S, Mao W, Fu L, et al. Elevated c-Src protein expression is an earlyevent in colonic neoplasia. Lab Invest 1998;78:365-71.
31. Villa E, Dugani A, Rebecchi AM, et al. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastro- enterology1996;110:1346-53.
32. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colo- rectal cancer screening bydetection of altered human DNA in stool: feasibilityof a multitarget assay panel. Gastroenterology2000;119:1219-27.
33. Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 2001; 93:1791 -8.
34. Benes CH, Wu N, Elia AE, Dharia T, Cantley LC, Soltoff SP. The C2 domain of PKC6 is a phosphotyro- sine binding domain. Cell 2005;121:271 -80.
35. Brodie C, Blumberg PM. Regulation of cell apopto- sis by protein kinase c 6. Apoptosis 2003;8:19-27.
36. Grossoni VC, Falbo KB, Kazanietz MG, de Kier Joffe ED, Urtreger AJ. Protein kinase C δ enhances proliferation and survival of murine mammarycells. Mol Carcinog 2007;46:381 -90.
37. Moasser MM, Srethapakdi M, Sachar KS,Kraker AJ, Rosen N. Inhibition of Src kinases bya selective tyrosine kinase inhibitor causes mitotic arrest. Cancer Res 1999;59:6145-52.
38. Biscardi JS, Belsches AP, Parsons SJ. Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol Carcinog 1998;21:261 -72.
39. Park J, MeislerAI, Cartwright CA. c-Yes tyrosine kinase activityin human colon carcinoma. Oncogene 1993;8:2627-35.